Market Research Report
Induced Pluripotent Stem Cells: Global Markets
|Published by||BCC Research||Product code||306082|
|Published||Content info||143 Pages
Delivery time: 1-2 business days
|Induced Pluripotent Stem Cells: Global Markets|
|Published: January 21, 2020||Content info: 143 Pages||
The global induced pluripotent stem cells (iPSC) market should reach $3.8 billion by 2024 from $2.4 billion in 2019 at a compound annual growth rate (CAGR) of 9.2% for the forecast period of 2019 to 2024.
The U.S. region of the global iPSC market is expected to grow from $1.2 billion in 2019 to $1.8 billion in 2024 at a CAGR of 8.8% for the forecast period of 2019 to 2024.
The Asia-Pacific region of the global iPSC market is expected to grow from $585 million in 2019 to $977 million in 2025 at a CAGR of 10.8% for the forecast period of 2019 to 2024.
This study is focused on the market side of iPSCs rather than its technical side. Different market segments for this emerging market are covered. For example, application-based market segments include academic research, drug development and toxicity testing, and regenerative medicine; product function-based market segments include molecular and cellular engineering, cellular reprogramming, cell culture, cell differentiation and cell analysis; iPSC-derived cell-type-based market segments include cardiomyocytes, hepatocytes, neurons, endothelia cells and other cell types; geography-based market segments include the U.S., Europe, Asia-Pacific and Rest of the World. Research and market trends are also analyzed by studying the funding, patent publications and research publications in the field.